Literature DB >> 23409762

Allosteric drugs and seven transmembrane receptors.

Terry Kenakin1.   

Abstract

Seven transmembrane Receptors (7TMRs) transmit signals through changes in conformation; the binding of ligands to any site on the receptor has the potential to change the receptor conformation. Allosteric ligands are defined as those which bind to sites other than the one needed for the endogenous receptor agonist (neurotransmitters, hormones). Allosteric ligand function is saturable (comes to a finite magnitude when the allosteric site is fully occupied) and probe dependent (the effects vary with different co-binding ligands). Both direct effects on receptor conformation and the induced effect on endogenous ligands must be considered when describing allosteric ligands; this paper will describe the quantitative models available to characterize these allosteric effects in molecular terms which can then be used to predict allosteric effects in all systems.

Mesh:

Substances:

Year:  2013        PMID: 23409762     DOI: 10.2174/1568026611313010003

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

1.  Allosteric modulation of sigma-1 receptors elicits anti-seizure activities.

Authors:  Lin Guo; Yanke Chen; Rui Zhao; Guanghui Wang; Eitan Friedman; Ao Zhang; Xuechu Zhen
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 2.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

3.  µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease.

Authors:  Erwan Bezard; Qin Li; Heather Hulme; Elva Fridjonsdottir; Anna Nilsson; Elsa Pioli; Per E Andren; Alan R Crossman
Journal:  J Neurosci       Date:  2020-07-20       Impact factor: 6.167

Review 4.  Employing novel animal models in the design of clinically efficacious GPCR ligands.

Authors:  Sophie J Bradley; Sajjad A Riaz; Andrew B Tobin
Journal:  Curr Opin Cell Biol       Date:  2013-12-31       Impact factor: 8.382

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.